Meenta is a Boston-based biotech company revolutionizing the way the world accesses diagnostic testing and laboratory capabilities. With a culture of innovation and a corporate philosophy to Give First, the team trained its sight on reforming biased and inefficient systems of scientific research funding.

Chasing grant funding through traditional routes can take up to 80% of a researcher’s time, and of the grant funding dispersed, a minority of the money tends to be spent on the research itself in lieu of operational costs and institutional overhead. The Meenta team knew these problems were preventing worthy scientists from pursuing important research questions, and generous individuals from backing scientific inquiry into the diseases and topics they care about most.